G1 Therapeutics Announces Initiation of New Phase 2 Trial of Trilaciclib in Combination with the Antibody-Drug Conjugate (ADC), Trodelvy® (Sacituzumab Govitecan-Hziy)
November 29, 2021 07:00 ET
|
G1 Therapeutics
RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company has initiated a Phase 2,...
Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium
November 19, 2021 09:55 ET
|
Arvinas Inc.
NEW HAVEN, Conn. and NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) announced today that updated safety and efficacy data from the Phase 1 dose...
Global Breast Cancer Therapeutics Market to Exhibit 13.1% CAGR and Hit USD 55.27 Billion till 2027 | Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™
November 17, 2021 05:41 ET
|
Fortune Business Insights
Pune, India, Nov. 17, 2021 (GLOBE NEWSWIRE) -- The global breast cancer therapeutics market is set to gain impetus from the ongoing research and developments to come up with state-of-the-art drugs....
Sermonix Pharmaceuticals Closes $40 Million Series A3 Financing Round Led by Perceptive Xontogeny Ventures Fund II
November 15, 2021 10:00 ET
|
Sermonix Pharmaceuticals LLC
Funds will be used to further advance lasofoxifene through late-stage clinical development as a next-generation oral SERM to treat women with increasingly prevalent ESR1 breast cancer mutationsInitial...
Global Breast Cancer Drugs Market (2021 to 2030) - Players Include Novartis, AstraZeneca and Celgene Among Others
November 11, 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
SBTX SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SBTX
November 10, 2021 14:22 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Arvinas to Present at Stifel 2021 Virtual Healthcare Conference
November 10, 2021 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Healthcare and Clinical Professionals Urged to Increase Women of Color Representation in Clinical Trials
November 04, 2021 13:21 ET
|
Sommer Consulting
JACKSONVILLE, Fla., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Women of color are severely underrepresented in clinical trials, missing out on potentially lifesaving treatment. This could also potentially...
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 03, 2021 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Biomerica Launches New Website for Its Aware® Breast Exam Device
October 29, 2021 08:19 ET
|
Biomerica, Inc.
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA)...